These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22806395)

  • 1. Rapamycin-sensitive mechanisms confine the growth of fission yeast below the temperatures detrimental to cell physiology.
    Morozumi Y; Mahayot F; Nakase Y; Soong JX; Yamawaki S; Sofyantoro F; Imabata Y; Oda AH; Tamura M; Kofuji S; Akikusa Y; Shibatani A; Ohta K; Shiozaki K
    iScience; 2024 Jan; 27(1):108777. PubMed ID: 38269097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between the mTOR and DNA Damage Response Pathways in Fission Yeast.
    Alao JP; Legon L; Rallis C
    Cells; 2021 Feb; 10(2):. PubMed ID: 33540829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine Stabilises Fission Yeast Wee1 in a Rad24-Dependent Manner but Attenuates Its Expression in Response to DNA Damage.
    Alao JP; Johansson-Sjölander J; Rallis C; Sunnerhagen P
    Microorganisms; 2020 Sep; 8(10):. PubMed ID: 33008060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of Mitotic Kinase Regulation: A Structural Perspective.
    Welburn JPI; Jeyaprakash AA
    Front Cell Dev Biol; 2018; 6():6. PubMed ID: 29459892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine stabilizes Cdc25 independently of Rad3 in Schizosaccharomyces pombe contributing to checkpoint override.
    Alao JP; Sjölander JJ; Baar J; Özbaki-Yagan N; Kakoschky B; Sunnerhagen P
    Mol Microbiol; 2014 May; 92(4):777-96. PubMed ID: 24666325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeine as a tool for investigating the integration of Cdc25 phosphorylation, activity and ubiquitin-dependent degradation in
    Alao JP; Sunnerhagen P
    Cell Div; 2020; 15():10. PubMed ID: 32612670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulating mammalian checkpoints through Cdc25 inactivation.
    Donzelli M; Draetta GF
    EMBO Rep; 2003 Jul; 4(7):671-7. PubMed ID: 12835754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboxy-terminal phosphorylation sites in Cdc25 contribute to enforcement of the DNA damage and replication checkpoints in fission yeast.
    Frazer C; Young PG
    Curr Genet; 2012 Aug; 58(4):217-34. PubMed ID: 22806395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of the Cdc25 phosphatase by the stress-activated Srk1 kinase in fission yeast.
    López-Avilés S; Grande M; González M; Helgesen AL; Alemany V; Sanchez-Piris M; Bachs O; Millar JB; Aligue R
    Mol Cell; 2005 Jan; 17(1):49-59. PubMed ID: 15629716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA damage and replication checkpoints in fission yeast require nuclear exclusion of the Cdc25 phosphatase via 14-3-3 binding.
    Zeng Y; Piwnica-Worms H
    Mol Cell Biol; 1999 Nov; 19(11):7410-9. PubMed ID: 10523629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1.
    Zeng Y; Forbes KC; Wu Z; Moreno S; Piwnica-Worms H; Enoch T
    Nature; 1998 Oct; 395(6701):507-10. PubMed ID: 9774107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cdc25 inhibited in vivo and in vitro by checkpoint kinases Cds1 and Chk1.
    Furnari B; Blasina A; Boddy MN; McGowan CH; Russell P
    Mol Biol Cell; 1999 Apr; 10(4):833-45. PubMed ID: 10198041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus type 1 Vpr induces cell cycle G2 arrest through Srk1/MK2-mediated phosphorylation of Cdc25.
    Huard S; Elder RT; Liang D; Li G; Zhao RY
    J Virol; 2008 Mar; 82(6):2904-17. PubMed ID: 18160429
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.